Paysign Inc
NASDAQ:PAYS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Paysign Inc
NASDAQ:PAYS
|
US |
Paysign Inc
PaySign, Inc. engages in the provision of prepaid card programs and processing services for corporate, consumer and government applications. The company is headquartered in Henderson, Nevada and currently employs 80 full-time employees. The company went IPO on 2001-07-19. The firm provides a card processing platform consisting of systems and software applications based on the needs of its clients. The company markets its prepaid card solutions under its Paysign brand. Its Paysign platform provides a variety of services, including transaction processing, cardholder enrolment, value loading, cardholder account management, reporting, and customer service. The firm has developed prepaid card programs for corporate incentives and rewards, including but not limited to, consumer rebates and rewards, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance. The firm manages all aspects of the prepaid card lifecycle, from the card design and approval processes with partners and networks, to production, packaging, distribution, and personalization.
PaySign, Inc. engages in the provision of prepaid card programs and processing services for corporate, consumer and government applications. The company is headquartered in Henderson, Nevada and currently employs 80 full-time employees. The company went IPO on 2001-07-19. The firm provides a card processing platform consisting of systems and software applications based on the needs of its clients. The company markets its prepaid card solutions under its Paysign brand. Its Paysign platform provides a variety of services, including transaction processing, cardholder enrolment, value loading, cardholder account management, reporting, and customer service. The firm has developed prepaid card programs for corporate incentives and rewards, including but not limited to, consumer rebates and rewards, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance. The firm manages all aspects of the prepaid card lifecycle, from the card design and approval processes with partners and networks, to production, packaging, distribution, and personalization.
Revenue: Full-year 2025 revenue was $82 million, up 40.5% year‑over‑year, driven by sharp growth in the patient affordability business.
Profitability: Net income nearly doubled to $7.6 million and operating margin expanded to 9% from 1.7%, evidence of meaningful operating leverage.
Patient affordability: Pharma revenue grew 167.8% to $33.9 million; the business processed ~79% more claims, added 55 programs (131 active) and delivered nearly $1 billion in patient assistance to >840,000 individuals.
Cost savings value: Their dynamic business rules saved clients over $325 million in 2025 and ~ $150 million so far this year — a core selling point.
Plasma business: Plasma revenue was $45.6 million, up 4%; exited 2025 with 595 centers (115 net added) and expect modest new openings in 2026.
Balance sheet & cash: Cash of $21.1 million at year end, no bank debt; company expects interest income of ~$3.1 million in 2026.
2026 guidance: Revenue $106.5M–$110.5M (30%–35% growth), gross margin 60%–62%, net income $13M–$16M ($0.21–$0.26 per diluted share) and adjusted EBITDA $30M–$33M.
Regulatory risk: Management does not view state-level accumulator/maximizer activity or DTC/cash-pay channels as a material threat today; ERISA limits state impact.
